vs
Side-by-side financial comparison of Delek US Holdings, Inc. (DK) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
Delek US Holdings, Inc. is the larger business by last-quarter revenue ($2.6B vs $1.5B, roughly 1.8× BeOne Medicines Ltd.). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs -7.7%, a 12.1% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs -4.9%). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs -10.8%).
Delek US Holdings, Inc. is an oil refining, logistics and biofuels company founded in 2001 and headquartered in Brentwood, Tennessee.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
DK vs ONC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.6B | $1.5B |
| Net Profit | $-201.3M | $66.5M |
| Gross Margin | -5.8% | 90.5% |
| Operating Margin | — | 12.4% |
| Net Margin | -7.7% | 4.4% |
| Revenue YoY | -4.9% | 32.8% |
| Net Profit YoY | — | 143.8% |
| EPS (diluted) | $-3.34 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.6B | — | ||
| Q4 25 | $2.4B | $1.5B | ||
| Q3 25 | $2.9B | $1.4B | ||
| Q2 25 | $2.8B | $1.3B | ||
| Q1 25 | $2.6B | $1.1B | ||
| Q4 24 | $2.4B | $1.1B | ||
| Q3 24 | $3.0B | $1.0B | ||
| Q2 24 | $3.3B | $929.2M |
| Q1 26 | $-201.3M | — | ||
| Q4 25 | $78.3M | $66.5M | ||
| Q3 25 | $178.0M | $124.8M | ||
| Q2 25 | $-106.4M | $94.3M | ||
| Q1 25 | $-172.7M | $1.3M | ||
| Q4 24 | $-413.8M | $-151.9M | ||
| Q3 24 | $-76.8M | $-121.3M | ||
| Q2 24 | $-37.2M | $-120.4M |
| Q1 26 | -5.8% | — | ||
| Q4 25 | 9.3% | 90.5% | ||
| Q3 25 | 13.8% | 86.1% | ||
| Q2 25 | 1.9% | 87.5% | ||
| Q1 25 | -2.4% | 85.2% | ||
| Q4 24 | -5.7% | 85.8% | ||
| Q3 24 | -0.7% | 83.0% | ||
| Q2 24 | 0.5% | 85.1% |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | 12.4% | ||
| Q3 25 | 10.2% | 11.5% | ||
| Q2 25 | -1.2% | 6.7% | ||
| Q1 25 | -4.8% | 1.0% | ||
| Q4 24 | -17.0% | -7.0% | ||
| Q3 24 | -4.0% | -12.0% | ||
| Q2 24 | 0.1% | -11.5% |
| Q1 26 | -7.7% | — | ||
| Q4 25 | 3.2% | 4.4% | ||
| Q3 25 | 6.2% | 8.8% | ||
| Q2 25 | -3.8% | 7.2% | ||
| Q1 25 | -6.5% | 0.1% | ||
| Q4 24 | -17.4% | -13.5% | ||
| Q3 24 | -2.5% | -12.1% | ||
| Q2 24 | -1.1% | -13.0% |
| Q1 26 | $-3.34 | — | ||
| Q4 25 | $1.23 | $0.05 | ||
| Q3 25 | $2.93 | $0.08 | ||
| Q2 25 | $-1.76 | $0.06 | ||
| Q1 25 | $-2.78 | $0.00 | ||
| Q4 24 | $-6.48 | $-0.10 | ||
| Q3 24 | $-1.20 | $-0.09 | ||
| Q2 24 | $-0.58 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $624.1M | $4.5B |
| Total DebtLower is stronger | $3.2B | $836.4M |
| Stockholders' EquityBook value | $302.0M | $4.4B |
| Total Assets | $7.6B | $8.2B |
| Debt / EquityLower = less leverage | 10.54× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $624.1M | — | ||
| Q4 25 | $625.8M | $4.5B | ||
| Q3 25 | $630.9M | $4.0B | ||
| Q2 25 | $615.5M | $2.8B | ||
| Q1 25 | $623.8M | $2.5B | ||
| Q4 24 | $735.6M | $2.6B | ||
| Q3 24 | $1.0B | $2.7B | ||
| Q2 24 | $657.9M | $2.6B |
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | $836.4M | ||
| Q3 25 | $3.2B | — | ||
| Q2 25 | $3.1B | — | ||
| Q1 25 | $3.0B | — | ||
| Q4 24 | $2.8B | — | ||
| Q3 24 | $2.8B | — | ||
| Q2 24 | $2.5B | — |
| Q1 26 | $302.0M | — | ||
| Q4 25 | $547.3M | $4.4B | ||
| Q3 25 | $444.8M | $4.1B | ||
| Q2 25 | $294.9M | $3.8B | ||
| Q1 25 | $429.4M | $3.5B | ||
| Q4 24 | $575.2M | $3.3B | ||
| Q3 24 | $875.4M | $3.4B | ||
| Q2 24 | $982.8M | $3.4B |
| Q1 26 | $7.6B | — | ||
| Q4 25 | $6.8B | $8.2B | ||
| Q3 25 | $7.1B | $7.6B | ||
| Q2 25 | $7.1B | $6.3B | ||
| Q1 25 | $6.9B | $5.8B | ||
| Q4 24 | $6.7B | $5.9B | ||
| Q3 24 | $7.0B | $5.8B | ||
| Q2 24 | $6.9B | $5.7B |
| Q1 26 | 10.54× | — | ||
| Q4 25 | 5.91× | 0.19× | ||
| Q3 25 | 7.14× | — | ||
| Q2 25 | 10.51× | — | ||
| Q1 25 | 7.07× | — | ||
| Q4 24 | 4.81× | — | ||
| Q3 24 | 3.19× | — | ||
| Q2 24 | 2.50× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $417.3M |
| Free Cash FlowOCF − Capex | — | $379.8M |
| FCF MarginFCF / Revenue | — | 25.4% |
| Capex IntensityCapex / Revenue | — | 2.5% |
| Cash ConversionOCF / Net Profit | — | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $502.8M | $417.3M | ||
| Q3 25 | $44.0M | $402.6M | ||
| Q2 25 | $51.4M | $263.6M | ||
| Q1 25 | $-62.4M | $44.1M | ||
| Q4 24 | $-163.5M | $75.2M | ||
| Q3 24 | $-21.6M | $188.4M | ||
| Q2 24 | $-48.4M | $-95.6M |
| Q1 26 | — | — | ||
| Q4 25 | $382.8M | $379.8M | ||
| Q3 25 | $-64.0M | $354.5M | ||
| Q2 25 | $-114.4M | $219.8M | ||
| Q1 25 | $-198.1M | $-12.3M | ||
| Q4 24 | $-354.0M | $-17.3M | ||
| Q3 24 | $-140.6M | $54.7M | ||
| Q2 24 | $-128.3M | $-205.5M |
| Q1 26 | — | — | ||
| Q4 25 | 15.8% | 25.4% | ||
| Q3 25 | -2.2% | 25.1% | ||
| Q2 25 | -4.1% | 16.7% | ||
| Q1 25 | -7.5% | -1.1% | ||
| Q4 24 | -14.9% | -1.5% | ||
| Q3 24 | -4.6% | 5.5% | ||
| Q2 24 | -3.9% | -22.1% |
| Q1 26 | — | — | ||
| Q4 25 | 4.9% | 2.5% | ||
| Q3 25 | 3.7% | 3.4% | ||
| Q2 25 | 6.0% | 3.3% | ||
| Q1 25 | 5.1% | 5.0% | ||
| Q4 24 | 8.0% | 8.2% | ||
| Q3 24 | 3.9% | 13.3% | ||
| Q2 24 | 2.4% | 11.8% |
| Q1 26 | — | — | ||
| Q4 25 | 6.42× | 6.28× | ||
| Q3 25 | 0.25× | 3.22× | ||
| Q2 25 | — | 2.79× | ||
| Q1 25 | — | 34.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
